← All trials
NCT07251153
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 28, 2025
- Primary completion
- Dec 18, 2025
- Completion date
- Oct 28, 2026
- First posted
- Nov 26, 2025
- Last posted
- Nov 26, 2025
- Enrollment
- 40
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Enyo PharmaLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.